SCHEMBL30453043

SCHEMBL30453043

Cc1c(-c2ccncc2)cnc(C#N)c1Cl

nearest known ligand 0.38

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 4/20 0.38
PDE3B Q13370 4/20 0.38
PDE3A Q14432 4/20 0.38
LMNA P02545 2/20 0.38
PTGS1 P23219 2/20 0.38
PDE5A O76074 1/20 0.38
HPGD P15428 1/20 0.38
TSHR P16473 1/20 0.38
PDE4A P27815 1/20 0.38
CYP2C19 P33261 1/20 0.38
BLM P54132 1/20 0.38
PDE4B Q07343 1/20 0.38
PDE4C Q08493 1/20 0.38
PDE4D Q08499 1/20 0.38
MAPK1 P28482 1/20 0.36
HSD17B10 Q99714 1/20 0.36
ALDH1A1 P00352 2/20 0.36
POLB P06746 1/20 0.36
DHODH Q02127 1/20 0.35
PDE10A Q9Y233 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24257513 1.00 KDM4E (0.38) KDM4EPDE3BPDE3ALMNAPTGS1
SCHEMBL24257695 0.84 KDM4E (0.45) KDM4EHPGDTSHRCYP2C19MAPK1
SCHEMBL30453176 0.84 KDM4E (0.45) KDM4EHPGDTSHRCYP2C19MAPK1
SCHEMBL24257735 0.81 ALOX15 (0.48) CYP2C19CYP11B1CYP11B2
SCHEMBL30546870 0.80 KDM4E (0.35) KDM4EPTGS1HPGDPDE4DALDH1A1
SCHEMBL24257763 0.80 KDM4E (0.35) KDM4EPTGS1HPGDPDE4DALDH1A1
SCHEMBL30454648 0.78 DHFR (0.44) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL24257698 0.78 DHFR (0.44) KDM4ELMNAHPGDALDH1A1NPC1
SCHEMBL24257731 0.78 LRRK2 (0.42) KDM4ELMNAHPGDTSHRCYP2C19
SCHEMBL24257776 0.77 KDM4E (0.41) KDM4ELMNAHPGDTSHRBLM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-116670131-A PHD inhibitor compounds, compositions, and methods of use 阿克比治疗有限公司 2023-08-29 CN disclosed
EP-4196466-A1 PHD INHIBITOR COMPOUNDS, COMPOSITIONS, AND METHODS OF USE Akebia Therapeutics Inc. (US) 2023-06-21 EP disclosed